SB-649,915

From Wikipedia, the free encyclopedia
  (Redirected from SB-649915)
Jump to: navigation, search
SB-649,915
SB-649,915 structure.png
Clinical data
ATC code none
Legal status
Legal status
  • Uncontrolled
Identifiers
CAS Number 420785-70-2 N
PubChem CID 10225553
IUPHAR/BPS 76
ChemSpider 8471882 N
ChEMBL CHEMBL183460 N
Chemical and physical data
Systematic (IUPAC) name: 6-[(1-[3-(2-methylquinolin-5-yl)oxypropyl]piperidin-4-yl)methyl]-4H-1,4-benzoxazin-3-one
3D model (Jmol) Interactive image
Formula C26H29N3O3
Molar mass 431.526 g/mol
 NYesY (what is this?)  (verify)

SB-649,915 is a serotonin reuptake inhibitor and 5-HT1A and 5-HT1B receptor antagonist which is being investigated for its antidepressant effects.[1] Relative to the selective serotonin reuptake inhibitors (SSRIs), SB-649,915 has a faster onset of action and may also have greater clinical efficacy as well.[1] This can be attributed to blockade of 5-HT1A and 5-HT1B autoreceptors which inhibit serotonin release.[1]

See also[edit]

References[edit]

  1. ^ a b c Starr KR, Price GW, Watson JM, Atkinson PJ, Arban R, Melotto S, Dawson LA, Hagan JJ, Upton N, Duxon MS (2007). "SB-649915-B, a novel 5-HT1A/B autoreceptor antagonist and serotonin reuptake inhibitor, is anxiolytic and displays fast onset activity in the rat high light social interaction test.". Neuropsychopharmacology. 32 (10): 2163–2172. doi:10.1038/sj.npp.1301341. PMID 17356576.